wavelifesciences.com (WVE): Operatsion rentabellik

Wave Life Sciences (WVE) kompaniyasining korporativ logotipi

Wave Life Sciences kompaniyasi PRISM tizimi orqali noyob stereotoza oligonucleotidlarini yaratadi. Soliqlar va foizlardan oldingi operatsion marja tebranishlarni namoyish etmoqda, bunda ko'rsatkich -320.90 ga yetdi. Sotuvlar mavjud emasligi sababli, moliyaviy barqarorlik kapital rezervlari va grantlarga asoslangan. Joriy biznes dinamikasi RNA dori vositalarining klinik sinovlari uchun hamkorlardan keladigan to'lovlarga tayanadi.

WVE: wavelifesciences.com Sotuvning operatsion marjasi 04.07.2022 - 19.11.2026

WVE (Wave Life Sciences Ltd.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Wave Life Sciences Corp
wavelifesciences.com asosiy tovari

Wave Life Sciences diversifikatsiyalangan logistika koridorlari va uzoq muddatli shartnomalar orqali nukleotid ta'minotining barqarorligini ta'minlaydi. Operatsion marja foizlar va soliqlar to'lanishidan oldingi daromadlarda asosiy faoliyatdan olingan foyda ulushini belgilaydi. Ushbu metrika ishlab chiqarish xarajatlarini boshqarish samaradorligini va operatsion chidamlilikni o'lchaydi. Pul oqimi bo'shliqlari xavflarini baholash uchun investorlarning ushbu ko'rsatkichni kuzatishi juda muhimdir. Operatsion marja darajasini tahlil qilish orqali samaradorlikning salbiy tendentsiyalarini o'z vaqtida aniqlash mumkin.

Muhim raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik